Lead exposure and conventional and ambulatory blood pressure: A prospective population study

JAMA

Volumn 275, Issue 20, 1996, Pages 1563-1570

  Staessen, Jan A ^a,c   Roels, Harry ^b   Fagard, Robert ^a  

^a Institute for International Law   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

LEAD;

ADULT; AGED; ALCOHOL CONSUMPTION; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CALCIUM BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; LEAD BLOOD LEVEL; LEAD POISONING; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SOCIOECONOMICS; SODIUM BLOOD LEVEL;

EID: 0029989791     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.20.1563     Document Type: Article

References (53)

1. Pirkle JL, Schwartz J, Landis JR, Harlan WR. The relationship between blood lead levels and blood pressure and its cardiovascular complications. Am J Epidemiol. 1985;121:246-258.
2. Staessen JA, Roels H, Lauwerys RR, Amery A. Low-level lead exposure and blood pressure. J Hum Hypertens. 1995;9:303-328.
3. Moller L, Kristensen TS. Blood lead as a cardiovascular risk factor. Am J Epidemiol. 1992;136: 1091-1100.
4. Weiss ST, Muñoz A, Stein A, Sparrow D, Speizer FE. The relationship of blood lead to blood pressure in a longitudinal study of working men. Am J Epidemiol. 1986;123:800-808.
5. Staessen JA, Dolenc P, Amery A, et al. Environmental lead exposure does not increase blood pressure in the population: evidence from the CadmiBel Study. J Hypertens. 1993;11(suppl 2):S35-S41.
6. The Scientific Committee. Consensus document on non-invasive ambulatory blood pressure monitoring. J Hypertens. 1990;8(suppl 6):S135-S140.
7. Lauwerys RR, Amery A, Bernard A, et al. Health effects of environmental exposure to cadmium: objectives, design, and organization of the CadmiBel Study, a cross-sectional morbidity study carried out in Belgium from 1985 to 1989. Environ Health Perspect. 1990;87:283-289.
8. Staessen JA, Lauwerys RR, Buchet JP, et al, for the CadmiBel Study Group. Impairment of renal function with increasing blood lead concentrations in the general population. N Engl J Med. 1992;327:151-156.
9. Petrie JC, O'Brien ET, Littler WA, de Swiet M. Recommendations on blood pressure measurement by a working party of the British Hypertension Society. BMJ. 1989;293:611-615.
10. O'Brien E, Mee F, Atkins N, O'Malley K. Evaluation of the SpaceLabs 90202 non-invasive ambulatory recorder according to the AAMI Standard and BHS criteria. J Hum Hypertens. 1991;5:223-226.
11. Staessen J, Bulpitt CJ, Fagard R, et al. Reference values for the ambulatory blood pressure and the blood pressure measured at home: a population study. J Hum Hypertens. 1991;5:355-361.
12. Thijs L, Staessen J, Fagard R. Analysis of the diurnal blood pressure curve. High Blood Pressure Cardiovasc Prev. 1992;1:17-28.
13. Office of Population Censuses and Surveys. Classification of Occupations and Coding Index. London, E ngland:Government Statistical Service; 1980.
14. McArdle WD, Katch FI, Katch VL. Exercise Physiology:Energy, Nutrition, and Human Performance. Philadelphia, Pa: Lea & Febiger; 1991:804.
15. Astrand PO, Rodahl K. Textbook of Work Physiology: Physiological Bases of Exercise. New York, NY: McGraw-Hill International Book Co; 1986:486.
16. Yamada Y, Ishizaki M, Kido T, et al. Alcohol, high blood pressure, and serum γ-glutamyl transpeptidase level. Hypertension. 1991;18:819-826.
17. Persyn JP, van der Silk W. A new method for the determination of γ-glutamyltransferase in serum. Z Klin Chem Klin Biochem. 1976;14:421-427.
18. Schmid RW, Reilley CN. New eomplexon for titration of calcium in the presence of magnesium. Anal Chem. 1957;29:264-268.
19. Claeys F, Ducoffre G, Sartor F, Roels H. Analytical quality control of cadmium and lead in blood and cadmium in urine: results of its implementation during a 5-year epidemiological study. In: Nordberg GF, Herber RFM, Alessio L, eds. Cadmium in the Human Environment: Toxidty and Carcinogenicity. Lyons, France: International Agency for Research on Cancer; 1992:83-92.
20. Siegel S, Castellan NJ Jr. The case of one sample: two measures or paired replicates. In: Nonparametric Statistics for the Behavioral Sciences. New York, NY: McGraw-Hill International Book Co; 1988:73-102.
21. Machin D, Campbell MJ. Statistical Tables for the Design of Clinical Trials. Oxford, England: Blackwell Scientific Publications; 1987:89.
22. Annest JL, Pirkle JL, Makuc D, Neese JW, Bayse DD, Kovar MG. Chronological trend in blood lead levels between 1976 and 1980. N Engl J Med. 1983;308:1373-1377.
23. Lockett CJ, Arbuckle D. Lead, ferritin, zinc, and hypertension. Bull Environ Contam Toxicol. 1987;38:975-980.
24. Harlan WR, Landis JR, Schmouder RL, Goldstein NG, Harlan LC. Blood lead and blood pressure: relationship in the adolescent and adult US population. JAMA. 1985;253:530-534.
25. Coate D, Fowles R. Is there statistical evidence for a blood lead-blood pressure relationship? J Health Econ. 1989;8:173-184.
26. Gartside PS. The relationship of blood lead levels and blood pressure in NHANES II: additional calculations. Environ Health Perspect. 1988;78:31-34.
27. Rabinowitz M, Bellinger D, Leviton A, Needleman H, Schoenbaum S. Pregnancy hypertension, blood pressure during labor, and blood lead levels. Hypertension. 1987;10:447-451.
28. Staessen JA, Bulpitt CJ, Fagard R, et al. Hypertension caused by low-level lead exposure: myth or fact? J Cardiovasc Risk. 1994;1:87-97.
29. Pocock SJ, Shaper AG, Ashby D, Delves T, Whitehead TP. Blood lead concentration, blood pressure, and renal function. BMJ. 1984;289:872-874.
30. Staessen J, Yeoman WB, Fletcher AE, et al. Blood lead concentration, renal function, and blood pressure in London civil servants. Br J Ind Med. 1990;47:442-447.
31. Pickering TG. Ambulatory Monitoring and Blood Pressure Variability. London, England: Science Press Ltd; 1991.
32. Conway J, Johnston J, Coats A, Somers V, Sleight P. The use of ambulatory blood pressure monitoring to improve the accuracy and to reduce the number of subjects in clinical trials of antihypertensive agents. J Hypertens. 1988;6:111-116.
33. Mancia G, Bertinieri G, Grassi G, et al. Effects of blood pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet. 1983;2:695-698.
34. Liu K, Cooper R, McKeever J, et al. Assessment of the association between habitual salt intake and high blood pressure: methodological problems. Am J Epidemiol. 1979;110:219-226.
35. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease, I: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
36. Kannel WB, Gordon T. Evaluation of cardiovascular risk in the elderly: the Framingham Study. Bull N Y Acad Med. 1978;54:573-591.
37. Mahaffey KR, Annest JL, Roberts J, Murphy RS. National estimates of blood lead levels: United States, 1976-1980: association with selected demographic and socioeconomic factors. N Engl J Med. 1982;307:573-579.
38. Intersalt Cooperative Study Group. Intersalt: an international study of electrolyte excretion and blood pressure: results for 24 hour urinary sodium and potassium excretion. BMJ. 1988;297:319-328.
39. Hjortland MC, McNamara PM, Kannel WB. Some atherogenic concomitants of menopause: the Framingham Study. Am J Epidemiol 1976;103:304-311.
40. Grandjean P, Hollnagel H, Hedegaard L, Christensen JM, Larsen S. Blood lead-blood pressure relations: alcohol intake and hemoglobin as confounders. Am J Epidemiol. 1989;129:732-739.
41. Neri LC, Hewitt D, Orser B. Blood lead and blood pressure: analysis of cross-sectional and longitudinal data from Canada. Environ Health Perspect. 1988;78:123-126.
42. Air Quality Criteria for Lead. Research Triangle Park, NC: US Environmental Protection Agency; 1986;1. Publication EPA-600/8-83/028aF.
43. Olsen NB, Hollnagel H, Grandjean P. Indicators of lead exposure in an adult Danish suburban population. Dan Med Bull. 1981;28:198-176.
44. Harlan WR, Hull AL, Schmouder RL, Thompson FE, Larkin FA, Landis JR. Blood pressure and nutrition in adults: the National Health and Nutrition Examination Survey. Am J Epidemiol. 1984; 120:17-28.
45. Kannel WB, Sorlie P. Hypertension in Framingham. In: Paul O, ed. Epidemiology and Control of Hypertension. Stuttgart, Germany: Georg Thieme Verlag; 1975:553-592.
46. Chabanel A, Chien S. Blood viscosity as a factor in human hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathaphysiology, Diagnosis, and Management. New York, NY: Raven Press; 1995;1:365-376.
47. Cooper WC, Wong O, Kheifets L. Mortality among employees of lead battery plants and lead-producing plants, 1947-1980. Scand J Work Environ Health. 1985;11:331-345.
48. Sharp DS, Becker CE, Smith AH. Chronic low-level lead exposure: its role in the pathogenesis of hypertension. Med Toxicol. 1987;2:210-232.
49. Staessen J, Amery A, Fagard R. Isolated systolic hypertension in the elderly. J Hypertens. 1990; 8:393-405.
50. Stadel BV. Oral contraceptives and cardiovascular disease. N Engl J Med. 1981;305:672-677.
51. Staessen J, Bulpitt CJ, Fagard R, Joossens JV, Lynen P, Amery A. Contraceptive pill use, urinary sodium and blood pressure: a population study in two Belgian towns. Acta Cardiol. 1984;39:55-64.
52. Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH. Prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med. 1988;319:1313-1317.
53. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease, II: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827-838.